To evaluate the hypothesis that CD133+ tumor spheres are more tumorigenic due to their enhanced stem-like properties, CD133+ tumor spheres and CD133− cells were subcutaneously injected into NOD/SCID mice in a limiting dilution assay (102, 103, 104 and 105 cells; Fig 6A). The gene discussed is PROM1; the disease is neoplasm.